Artery stiffness may predict balloon pump success in heart shock

NCT ID NCT07402018

Recruiting now Knowledge-focused Sponsor: Thomas Jefferson University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational pilot study at Thomas Jefferson University will enroll 20 adults with cardiogenic shock who are already receiving an intra-aortic balloon pump (IABC). Researchers will measure baseline arterial compliance (how stiff the arteries are) and then track heart function and outcomes. The goal is to see if patients with stiffer arteries respond differently to IABC, which could guide future treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors decide which cardiogenic shock patients benefit most from an intra-aortic balloon pump.
What could go wrong: This is a very small pilot study (20 people) that only observes outcomes, not tests a treatment. It may not lead to clear conclusions or change practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiogenic shock Shock, Cardiogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOGENIC SHOCK IABC PROCEDURE INTRAAORTIC BALLOON COUNTERPULSATION (IABC)

Contacts and locations

Locations

Thomas Jefferson University Hospital
RECRUITING

Philadelphia, Pennsylvania, 19107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.